VBIV - VBI Vaccines EV/EBITDA Multiple

Corporate company logo of VBI Vaccines, Inc. (VBIV)

The VBI Vaccines Inc. (VBIV) ecosystem relies on innovative VLP technologies that mimic viral structures to enhance immunity. In a crowded hepatitis drug market, the company is betting on government contracts and emerging regions. This chart on GURU.Markets shows an EV/EBITDA multiple of . The business is currently scaling its eVLP platform, aiming to secure a dominant position in virology through the launch of the PreHevbrio vaccine.

VBIV VBI Vaccines Inc: Business Value to Operating Income Before Depreciation in the range 07/04/2022 - 11/16/2026

Analytical breakdowns for VBI Vaccines Inc.

- stock price and consensus target price:
Summary company analytics:vbivaccines.com VBIV
Original product of VBI Vaccines, Inc.

The multiple compares the total enterprise value, including debt, against its earnings before interest, taxes, depreciation, and amortization. This metric serves as a long-term stress-testing tool, identifying asset stagnation or maturity through volatility analysis. The EV/EBITDA ratio on the price chart confirms the efficiency of the VBI Vaccines Inc. (VBIV) model, where the combination of proprietary developments and external serial production optimizes capital expenditures.

Who VBI Vaccines Inc. competes with

Gilead Sciences, Inc. - Enterprise Value to EBITDA Ratio|Cidara Therapeutics, Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Novavax Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio CureVac NV CVAC|Valneva Pharma (VALN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Vir Corp (VIR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio SIGA|Emergent BioSolutions (EBS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atea Pharma (AVIR)|Total Company Value to Operating Income Before Depreciation Ratio Invivyd|EV/EBITDA Multiple ENTA (enanta.com)|INO: Enterprise Value to Operating Income Before Depreciation|hillevax.com - EV/EBITDA Multiple|KLRS - EV/EBITDA Multiple|DYAI: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation NNVC|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Talphera|COCP: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Traws Therapeutics (TRAW)|DWTX - Company Value to EBITDA|EV/EBITDA Multiple QLGN (qualigeninc.com)|Total Company Value to Operating Income Before Depreciation Ratio AlloVir, Inc. (ALVR)|VIRI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VXRT (vaxart.com)